Published date: 30 May 2017

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Closing: 29 June 2017

Contract summary

Industry

  • Pharmaceutical products - 33600000

Location of contract

North East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West

Value of contract

£710,890,000

Procurement reference

tender_141347/587620

Published date

30 May 2017

Closing date

29 June 2017

Contract start date

1 September 2017

Contract end date

31 August 2019

Contract type

Not specified

Procedure type

Open procedure

Any interested supplier may submit a tender in response to an opportunity notice.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

NHS Framework Agreement for Branded Pharmaceuticals for London - Tranche B
and Interim Biosimilars for Midlands & East, North of England and South of England

Offer reference number: CM/PHR/14/5446

Period of framework agreement:
CM/PHR/14/5446/01 - 1 September 2017 - 31 August 2019 with an option to extend for up to 24 months

CM/PHR/14/5446/02 -
North of England 1September 2017 - 28 February 2018 with an option to extend for up to 6 months
South of England - 1 September 2017 - 31 August 2018 with an option to extend for up to 12 months
Midlands and East - 1 September 2017 - 28 February 2019 with an option to extend for up to 18 months

More information

Attachments

Links

Additional text

The procurement exercise is being conducted on the NHS England eTendering portal at www.nhsengland.bravosolution.co.uk the project code is tender_616 and the ITT code is itt_285. This is where the ITO documents are available.

About the buyer

Contact name

Michelle Clarke

Address

NHS England, Commercial Medicines Unit, 2nd Floor, Rutland House
Runcorn, Cheshire
WA7 2ES
England

Email

michelle.clarke6@nhs.net